Baidu
map

特殊的手术:印度一男子边做脑部手术边弹吉他

2017-07-24 佚名 中新网

印度一名音乐家因罹患“肌张力障碍”而需在手术期间边弹吉他边动手术,以便医生能准确地“燃烧”受阻的脑神经。


据外媒报道,印度一名音乐家因罹患“肌张力障碍”而需在手术期间边弹吉他边动手术,以便医生能准确地“燃烧”受阻的脑神经。

据悉,印度音乐家阿比瑟因患上一种罕见的“肌张力障碍”,导致他的手指在弹吉他时会突然痉挛,这一疾病也被称为“音乐家肌张力障碍”

起初,阿比瑟以为这是因为练习过度,但经过几番尝试,他发现只有在弹吉他时,手指才会出现僵硬的情况,便到处求医。

他说:“一些医生告诉我这是肌肉过劳,只给我一些止痛药、维他命及抗生素等”。

直到9个月前,一名神经学家才诊断出,阿比瑟患的是“肌张力障碍”,建议阿比瑟接受开脑手术。

医生表示:“由于症状只出现在患者弹吉他的时候,所以患者在手术时需保持清醒及弹吉他,因为当中的反应可以让医生更准确锁定目标位置。”

阿比瑟对手术的结果感到惊讶,他说:“到了第六次(燃烧)时,我的手指已可运动自如,尤其在手术结束后,我的手指已经恢复到原来的状态了。”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=225792, encodeId=370e225e92ea, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jul 24 12:04:35 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225784, encodeId=f7fb225e84e6, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jul 24 11:50:24 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225773, encodeId=5539225e73d3, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQplCaQGBmjHytXQqvsuocO2uV2lOAaJibzDafJudKToVfU12LzwArHDb4TSrmU2hk5Qxzc6icoicBK3Dg/0, createdBy=a7901968505, createdName=明心见性, createdTime=Mon Jul 24 11:39:33 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225760, encodeId=9461225e60b3, content=学习,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Mon Jul 24 11:29:08 CST 2017, time=2017-07-24, status=1, ipAttribution=)]
    2017-07-24 1dd8c52fm63(暂无匿称)

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=225792, encodeId=370e225e92ea, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jul 24 12:04:35 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225784, encodeId=f7fb225e84e6, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jul 24 11:50:24 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225773, encodeId=5539225e73d3, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQplCaQGBmjHytXQqvsuocO2uV2lOAaJibzDafJudKToVfU12LzwArHDb4TSrmU2hk5Qxzc6icoicBK3Dg/0, createdBy=a7901968505, createdName=明心见性, createdTime=Mon Jul 24 11:39:33 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225760, encodeId=9461225e60b3, content=学习,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Mon Jul 24 11:29:08 CST 2017, time=2017-07-24, status=1, ipAttribution=)]
    2017-07-24 Y—xianghai

    学习了新知识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=225792, encodeId=370e225e92ea, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jul 24 12:04:35 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225784, encodeId=f7fb225e84e6, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jul 24 11:50:24 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225773, encodeId=5539225e73d3, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQplCaQGBmjHytXQqvsuocO2uV2lOAaJibzDafJudKToVfU12LzwArHDb4TSrmU2hk5Qxzc6icoicBK3Dg/0, createdBy=a7901968505, createdName=明心见性, createdTime=Mon Jul 24 11:39:33 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225760, encodeId=9461225e60b3, content=学习,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Mon Jul 24 11:29:08 CST 2017, time=2017-07-24, status=1, ipAttribution=)]
    2017-07-24 明心见性

    学习了,谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=225792, encodeId=370e225e92ea, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Jul 24 12:04:35 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225784, encodeId=f7fb225e84e6, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jul 24 11:50:24 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225773, encodeId=5539225e73d3, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQplCaQGBmjHytXQqvsuocO2uV2lOAaJibzDafJudKToVfU12LzwArHDb4TSrmU2hk5Qxzc6icoicBK3Dg/0, createdBy=a7901968505, createdName=明心见性, createdTime=Mon Jul 24 11:39:33 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225760, encodeId=9461225e60b3, content=学习,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Mon Jul 24 11:29:08 CST 2017, time=2017-07-24, status=1, ipAttribution=)]
    2017-07-24 执着追梦

    学习,谢谢分享

    0

相关资讯

LANCET NEUROL:苍白球刺激治疗原发性肌张力障碍

  原发性肌张力障碍的严重型很难用药物控制。一个多中心对照研究证实了苍白球神经刺激对原发性全身性或局灶性肌张力患者的安全性和有效性。德国科尔的Christian-Albrechts大学神经科的Jens Volkmann博士等人对这项研究的研究对象延长随访时间5年发现:延长随访时间的结果依然支持苍白球刺激治疗严重原发性肌张力障碍的安全性和有效性,可推荐作为药物治疗效果不佳的严重全身性或局灶性肌张力障

综述:脑深部电刺激术治疗肌张力障碍的研究进展

肌张力障碍是一组因肌肉持续收缩导致扭曲、重复运动或者姿势异常为特征的临床综合征,也可表现为主动运动时、与目的运动无关的肌肉参与收缩出现的异常活动。目前,越来越多的研究发现脑深部电刺激术(deep brainstimulation,DBS)对治疗肌张力障碍可取得较好的疗效。 一、DBS治疗肌张力障碍的机制研究 相对于DBS治疗帕金森病,DBS对肌张力障碍的治疗疗效多数是缓慢进

Neurobiol Dis:肌张力障碍和帕金森病的丘脑底核电信号研究获进展

肌张力障碍(dystonia)是主动肌与拮抗肌收缩不协调或过度收缩引起的以肌张力异常的动作和姿势为特征的运动障碍综合征,与帕金森病(Parkinson’s disease)都属于神经系统疾病,并可通过深部脑刺激(deep brain stimulation,DBS)丘脑底核(subthalamic nucleus, STN)缓解症状。然而,两类疾病的STN神经波动是否具有特殊的病理特征,仍然不甚清

Neurology:左旋多巴在肌张力障碍中的应用

研究者认为应该改变对所有早发性肌张力障碍患者都使用左旋多巴治疗的临床原则,采用更为理性个性化的治疗手段

Baidu
map
Baidu
map
Baidu
map